1. Food and Drug Administration. Statement Regarding the Demonstrations of Effectiveness of Human Drug Products and Devices. Federal Register. Vol. 60 No. 147, August 1, 1995, Docket No. 95-0230: 39180–1.
2. Points to Consider on Application with 1) Meta-analyses and 2) One Pivotal Study;Committee for Proprietary Medicinal Products,2001
3. Reflection Paper on Methodological Issues in Confirmatory Clinical Trials Planned with an Adaptive Design;Committee for Medicinal Products for Human Use,2007
4. Sample size reestimation in clinical trials;Shih,1992
5. Sample size reestimation for triple blind clinical trials;Shih;Drug Inf J,1993